Literature DB >> 8834249

Scanning the first part of the neurofibromatosis type 1 gene by RNA-SSCP: identification of three novel mutations and of two new polymorphisms.

P Gasparini1, L D'Agruma, G Pio de Cillis, P Balestrazzi, R Mingarelli, L Zelante.   

Abstract

Neurofibromatosis type 1 (NF1) of von Recklinghausen is a common autosomal dominant disorder, characterized by peripheral neurofibromas, café-au-lait spots and Lisch nodules of the iris. The high mutation rate at the NF1 locus results in a wide range of molecular abnormalities. We have scanned 14 different exons from the first part of the NF1 gene using the RNA-single strand conformation polymorphism (RNA-SSCP) method in a series of 40 NF1 patients. Three novel mutations, two nonsense and one missense, and two polymorphisms have been detected in familial cases. Genotype-phenotype correlations have been investigated, but no particular association has been detected. After this screening, the majority of NF1 chromosomes has not yet been characterized, confirming the difficulty in detecting the defect underlying NF1 in most families, even following extensive DNA analysis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8834249     DOI: 10.1007/bf02267073

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  22 in total

1.  Restriction site generating-polymerase chain reaction (RG-PCR) for the probeless detection of hidden genetic variation: application to the study of some common cystic fibrosis mutations.

Authors:  P Gasparini; A Bonizzato; M Dognini; P F Pignatti
Journal:  Mol Cell Probes       Date:  1992-02       Impact factor: 2.365

2.  NF1-related locus on chromosome 15.

Authors:  E Legius; D A Marchuk; B K Hall; L B Andersen; M R Wallace; F S Collins; T W Glover
Journal:  Genomics       Date:  1992-08       Impact factor: 5.736

3.  Development of RNA-SSCP protocols for the identification and screening of CFTR mutations: identification of two new mutations.

Authors:  L Bisceglia; A Grifa; L Zelante; P Gasparini
Journal:  Hum Mutat       Date:  1994       Impact factor: 4.878

4.  Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus.

Authors:  D Viskochil; A M Buchberg; G Xu; R M Cawthon; J Stevens; R K Wolff; M Culver; J C Carey; N G Copeland; N A Jenkins
Journal:  Cell       Date:  1990-07-13       Impact factor: 41.582

5.  An analysis of variation in expression of neurofibromatosis (NF) type 1 (NF1): evidence for modifying genes.

Authors:  D F Easton; M A Ponder; S M Huson; B A Ponder
Journal:  Am J Hum Genet       Date:  1993-08       Impact factor: 11.025

6.  Differential expression of two types of the neurofibromatosis type 1 (NF1) gene transcripts related to neuronal differentiation.

Authors:  T Nishi; P S Lee; K Oka; V A Levin; S Tanase; Y Morino; H Saya
Journal:  Oncogene       Date:  1991-09       Impact factor: 9.867

7.  Screening of neurofibromatosis type 1 gene: identification of a large deletion and of an intronic variant.

Authors:  A Grifa; M R Piemontese; S Melchionda; P Origone; L Zelante; D Coviello; G Fratta; B Dallapiccola; P Balestrazzi; F Ajmar
Journal:  Clin Genet       Date:  1995-06       Impact factor: 4.438

8.  Mutational analysis of patients with neurofibromatosis 2.

Authors:  M MacCollin; V Ramesh; L B Jacoby; D N Louis; M P Rubio; K Pulaski; J A Trofatter; M P Short; C Bove; R Eldridge
Journal:  Am J Hum Genet       Date:  1994-08       Impact factor: 11.025

9.  Molecular diagnosis of familial adenomatous polyposis.

Authors:  S M Powell; G M Petersen; A J Krush; S Booker; J Jen; F M Giardiello; S R Hamilton; B Vogelstein; K W Kinzler
Journal:  N Engl J Med       Date:  1993-12-30       Impact factor: 91.245

10.  Genomic organization of the neurofibromatosis 1 gene (NF1).

Authors:  Y Li; P O'Connell; H H Breidenbach; R Cawthon; J Stevens; G Xu; S Neil; M Robertson; R White; D Viskochil
Journal:  Genomics       Date:  1995-01-01       Impact factor: 5.736

View more
  6 in total

1.  Molecular diagnosis of neurofibromatosis type 1: 2 years experience.

Authors:  Siân Griffiths; Peter Thompson; Ian Frayling; Meena Upadhyaya
Journal:  Fam Cancer       Date:  2007       Impact factor: 2.375

2.  Exploring the somatic NF1 mutational spectrum associated with NF1 cutaneous neurofibromas.

Authors:  Laura Thomas; Gill Spurlock; Claire Eudall; Nick S Thomas; Matthew Mort; Stephen E Hamby; Nadia Chuzhanova; Hilde Brems; Eric Legius; David N Cooper; Meena Upadhyaya
Journal:  Eur J Hum Genet       Date:  2011-11-23       Impact factor: 4.246

3.  The use of next-generation sequencing in molecular diagnosis of neurofibromatosis type 1: a validation study.

Authors:  Ryo Maruoka; Toshiki Takenouchi; Chiharu Torii; Atsushi Shimizu; Kumiko Misu; Koichiro Higasa; Fumihiko Matsuda; Arihito Ota; Katsumi Tanito; Akira Kuramochi; Yoshimi Arima; Fujio Otsuka; Yuichi Yoshida; Keiji Moriyama; Michihito Niimura; Hideyuki Saya; Kenjiro Kosaki
Journal:  Genet Test Mol Biomarkers       Date:  2014-10-17

4.  Neurofibromatosis type 1 (NF1): a protein truncation assay yielding identification of mutations in 73% of patients.

Authors:  V M Park; E K Pivnick
Journal:  J Med Genet       Date:  1998-10       Impact factor: 6.318

5.  Deletions of NF1 gene and exons detected by multiplex ligation-dependent probe amplification.

Authors:  A De Luca; I Bottillo; M C Dasdia; A Morella; V Lanari; L Bernardini; L Divona; S Giustini; L Sinibaldi; A Novelli; I Torrente; A Schirinzi; B Dallapiccola
Journal:  J Med Genet       Date:  2007-12       Impact factor: 6.318

6.  Clinical characteristics and spectrum of NF1 mutations in 12 unrelated Chinese families with neurofibromatosis type 1.

Authors:  Bin Mao; Siyu Chen; Xin Chen; Xiumei Yu; Xiaojia Zhai; Tao Yang; Lulu Li; Zheng Wang; Xiuli Zhao; Xue Zhang
Journal:  BMC Med Genet       Date:  2018-06-18       Impact factor: 2.103

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.